MKI67 and hepatocellular carcinoma: Human mesenchymal stem cells (hMSCs) promote the growth of HCC by activating the MAPK pathway to increase the expression of proliferation‐related proteins Ki‐67, pHH3, and PCNA, and boost the metastasis of HCC through EMT and ITGA5.